Targeting FGF for third-line treatment of mRCC

被引：0
|
作者：
Sarah Payton
机构：
来源：
Nature Reviews Urology | 2014年 / 11卷 / 4期
关键词：
D O I：
10.1038/nrurol.2014.55
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：186 / 186
相关论文
共 50 条
  • [1] ACTIVITY OF SUNITINIB AS THIRD-LINE TREATMENT OF METASTATIC RENAL CELL CARCINOMA (MRCC) (JAPAN)
    Nozawa, M.
    Mochida, Y.
    Nishigaki, K.
    Nagae, S.
    Uemura, H.
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (03) : I11 - I11
  • [2] Third-line therapy in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC)
    Heng, Daniel Yick Chin
    Stukalin, Igor
    Wells, Connor
    Donskov, Frede
    Rini, Brian I.
    Lee, Jae-Lyun
    Bjarnason, Georg A.
    Beuselinck, Benoit
    Smoragiewicz, Martin
    Alva, Ajjai Shivaram
    Srinivas, Sandy
    Wood, Lori
    Brugarolas, James
    Pal, Sumanta Kumar
    Yuasa, Takeshi
    Broom, Reuben James
    Kanesvaran, Ravindran
    Bamias, Aristotelis
    Knox, Jennifer J.
    Choueiri, Toni K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] Treatment of epilepsy with third-line antiepileptic drugs
    Chahem, J.
    Bauer, J.
    [J]. NERVENARZT, 2007, 78 (12): : 1407 - 1412
  • [4] Third-Line Treatment Options for Kidney Cancer
    Posadas, Edwin M.
    Limvorasak, Suwicha
    Figlin, Robert A.
    [J]. ONCOLOGY-NEW YORK, 2016, 30 (09): : 813 - +
  • [5] Targeted treatment beyond third-line in metastatic Renal Cell Carcinoma (mRCC): Single center outcome of 22 patients
    Vallet, S.
    Hoefner, T.
    Pahernik, S.
    Tosev, G.
    Hadaschik, B.
    Duensing, S.
    Hohenfellner, M.
    Jaeger, D.
    Gruellich, C.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 91 - 91
  • [6] Evolving Third-Line Treatment Options for Follicular Lymphoma
    Burke, John M.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (06) : 394 - 396
  • [7] Metastatic Colorectal Cancer: Strategies for Third-Line Treatment
    Marshall, John L.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (01) : 7 - 15
  • [8] Third-line treatment with quinacrine and metronidazole in refractory giardiasis
    Hunstig, Friederike
    Jochum, Johannes
    Tannich, Egbert
    Kreuels, Benno
    [J]. FLUGMEDIZIN TROPENMEDIZIN REISEMEDIZIN, 2020, 27 (05): : 216 - 218
  • [9] First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC
    Ko, J. J.
    Choueiri, T. K.
    Rini, B. I.
    Lee, J-L
    Kroeger, N.
    Srinivas, S.
    Harshman, L. C.
    Knox, J. J.
    Bjarnason, G. A.
    MacKenzie, M. J.
    Wood, L.
    Vaishampayan, U. N.
    Agarwal, N.
    Pal, S. K.
    Tan, M-H
    Rha, S. Y.
    Yuasa, T.
    Donskov, F.
    Bamias, A.
    Heng, D. Y. C.
    [J]. BRITISH JOURNAL OF CANCER, 2014, 110 (08) : 1917 - 1922
  • [10] Treatment of autoimmune hepatitis—First-line, second-line and third-line treatment
    Taubert R.
    Engel B.
    [J]. Die Innere Medizin, 2024, 65 (4) : 325 - 333
12345